Category: Latest News
-
Egyptian court hands nine policemen jail terms for assaulting doctors
An Egyptian court sentenced nine policemen to three years in prison on Tuesday for physically and verbally assaulting two doctors at a Cairo hospital in January, an incident that prompted strikes and a protest demanding justice. The policemen are not in jail. Momin Abdelazim, one of the two doctors allegedly involved, told Reuters at the…
-
Allergan to buy Tobira in push for fatty liver disease drugs
Just hours later on Tuesday, Allergan announced it would also pay $50 million upfront and make future milestone payments for Akarna Therapeutics Ltd, a privately held company that is planning early-stage studies of a treatment for NASH. There are no approved treatments for the disease affecting more than 15 million Americans, which involves accumulation of…
-
Allergan to buy Tobira in push for fatty liver disease drugs
Just hours later on Tuesday, Allergan announced it would also pay $50 million upfront and make future milestone payments for Akarna Therapeutics Ltd, a privately held company that is planning early-stage studies of a treatment for NASH. There are no approved treatments for the disease affecting more than 15 million Americans, which involves accumulation of…
-
Drug resistance in people and animals may push millions into poverty: World Bank
By Alex Whiting ROME (Thomson Reuters Foundation) – If drug-resistant infections in people and animals are allowed to spread unchecked, some 28 million people will fall into poverty by 2050, and a century of progress in health will be reversed, the World Bank said on Monday. By 2050, annual global GDP would fall by at least…
-
Astellas, Vical herpes vaccine fails mid-stage study
(Reuters) – Japan’s Astellas Pharma Inc and San Diego-based Vical Inc said their experimental herpes vaccine failed a mid-stage study involving certain kidney transplant patients. Vical’s shares was down about 18 percent in light premarket trading on Monday. The DNA vaccine, ASP0113, is designed to prevent cytomegalovirus (CMV) disease in patients receiving a renal transplant…
-
GSK cuts vaccine price for refugees, bowing to pressure
GlaxoSmithKline is cutting the price charged for its pneumococcal vaccine when given to refugees, following complaints about the product's “exorbitant” cost by medical charity Medecins Sans Frontieres. GSK said its offer was made on the basis that others would not seek to reference the special price, which is intended solely to support refugee populations. Pfizer…
-
Data leak boosts Froome, puts Wiggins in spotlight
By Alan Baldwin LONDON (Reuters) – Chris Froome's credibility as triple Tour de France champion has only been boosted by the hacking of his private medical information, according to a South African physiologist who carried out tests on the Briton last year. Jeroen Swart, in an interview with the Cycling Tips website, suggested, however, that…
-
Cycling-Data leak boosts Froome, puts Wiggins in spotlight
By Alan Baldwin LONDON, Sept 19 (Reuters) – Chris Froome’s credibility as triple Tour de France champion has only been boosted by the hacking of his private medical information, according to a South African physiologist who carried out tests on the Briton last year. Jeroen Swart, in an interview with the Cycling Tips website, suggested,…
-
Cycling-Data leak boosts Froome, puts Wiggins in spotlight
By Alan Baldwin LONDON, Sept 19 (Reuters) – Chris Froome’s credibility as triple Tour de France champion has only been boosted by the hacking of his private medical information, according to a South African physiologist who carried out tests on the Briton last year. Jeroen Swart, in an interview with the Cycling Tips website, suggested,…
-
Canadian smart sport bra maker gets $10 million to take on fitness giants
By Alastair Sharp TORONTO (Reuters) – A small Canadian company has raised $10 million to take on Nike Inc , Under Armour Inc and others with a sensor-rich sports bra its chief executive says is more useful than a smart watch and more comfortable than a heart rate monitor. Montreal-based OMsignal hopes the funding round,…